Private equity and investment-services firm focused on alternative asset management and middle-market buyouts, with sponsor-backed and family-office capital deployment. Pinney & Scofield Inc. positions itself as a sector-agnostic investor targeting operationally intensive businesses in manufacturing, healthcare services and niche consumer brands, offering control and growth-oriented capital, board-level operational support and exit planning for strategic sales or recapitalizations.
Private equity and investment-services firm focused on alternative asset management and middle-market buyouts, with sponsor-backed and family-office capital deployment. Pinney & Scofield Inc. positions itself as a sector-agnostic investor targeting operationally intensive businesses in manufacturing, healthcare services and niche consumer brands, offering control and growth-oriented capital, board-level operational support and exit planning for strategic sales or recapitalizations.
Targets middle-market control investments in operationally intensive businesses across manufacturing, healthcare services and niche consumer brands. Emphasizes a hands-on private equity playbook: buy-and-build value creation, operational improvement, margin expansion and governance upgrades. Prefers sponsor-backed and family-office capital structures, flexible hold periods tied to execution of strategic exits or recapitalizations. Underwriting blends cashflow resilience, unit economics and management continuity; risk managed through concentrated portfolio construction, staged capital with operational KPIs, and active board-level involvement to accelerate EBITDA growth and liquidity creation.
Targets middle-market control investments in operationally intensive businesses across manufacturing, healthcare services and niche consumer brands. Emphasizes a hands-on private equity playbook: buy-and-build value creation, operational improvement, margin expansion and governance upgrades. Prefers sponsor-backed and family-office capital structures, flexible hold periods tied to execution of strategic exits or recapitalizations. Underwriting blends cashflow resilience, unit economics and management continuity; risk managed through concentrated portfolio construction, staged capital with operational KPIs, and active board-level involvement to accelerate EBITDA growth and liquidity creation.
| Trades 711 | Longs Won 530/711 74% | Profit Factor 52.06 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $649,397.46 |
| Average Win $113,475.7 | Best Trade (Mar 30) $11.75M | Sharpe Ratio -357.95 |
| Average Loss -$6,383.15 | Worst Trade (Sep 01) -$105,467.43 | Z-Score 18.17 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2w 4d | Expectancy $82,959.52 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% |
| Consecutive Losing Trades | 32,258 | 29,032 | 25,806 | 22,581 | 19,355 | 16,129 | 12,903 | 9,677 | 6,452 | 3,226 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 5318 53184C118 | 2,500 | $27,350 | $27,350 | - | - | - | 0.0 |
AAPL Apple Inc. | 22,530 | $5.57M | $7.06M | - | $1.48M | 26.63% | +0.294% |
ABBV AbbVie Inc. | 478 | $87,221.82 | $117,535.42 | - | $30,313.6 | 34.75% | +0.828% |
ABT Abbott Laboratories | 132 | $13,552 | $14,230.92 | - | $678.92 | 5.01% | -0.139% |
ACB Aurora Cannabis Inc. | 400 | $1,700 | $1,188 | - | -$512 | -30.12% | -0.336% |
ADI Analog Devices, Inc. | 241 | $51,714.39 | $93,944.21 | - | $42,229.82 | 81.66% | +3.313% |
ADM Archer-Daniels-Midland Co | 500 | $36,345 | $38,290 | - | $1,945 | 5.35% | -1.2% |
ADP Automatic Data Processing Inc. | 450 | $131,729 | $122,103 | - | -$9,626 | -7.31% | -0.793% |
AEG Aegon N.V. | 714 | $4,205 | $6,811.56 | - | $2,606.56 | 61.99% | +0.846% |
AEVA Aeva Technologies, Inc. | 100 | $1,316 | $2,659 | - | $1,343 | 102.05% | +5.265% |
AGG iShares Core U.S. Aggregate Bond ETF | 1,192 | $118,330 | $116,345.16 | - | -$1,984.84 | -1.68% | +0.18% |
AKAM Akamai Technologies Inc. | 225 | $21,317.85 | $24,864.75 | - | $3,546.9 | 16.64% | -6.782% |
ALLO Allogene Therapeutics Inc. | 192 | $409 | $384.96 | - | -$24.04 | -5.88% | +1.777% |
AMD Advanced Micro Devices, Inc. | 262 | $39,181.47 | $126,671.76 | - | $87,490.29 | 223.3% | -1.185% |
AMGN Amgen Inc. | 200 | $62,276 | $82,196 | - | $19,920 | 31.99% | +1.514% |
AMT American Tower Corporation | 265 | $48,603.47 | $45,717.8 | - | -$2,885.67 | -5.94% | +0.771% |
AMZN Amazon.com Inc | 2,260 | $489,995.29 | $620,234.4 | - | $130,239.11 | 26.58% | +0.801% |
ANET Arista Networks, Inc. | 30 | $3,683 | $5,658 | - | $1,975 | 53.62% | -1.934% |
ARM Arm Holdings plc American Depositary Receipt | 40 | $6,051 | $11,305.6 | - | $5,254.6 | 86.84% | -1.409% |
ASML ASML Holding N.V. New York Registry Shares | 5 | $3,465 | $8,705.57 | - | $5,240.57 | 151.24% | +2.156% |